Embolization Products Market: By Product Type (Embolization Coils, Microspheres or Microbeads, Catheters), By Embolization Type (Arterial Embolization, Chemoembolization, Radioembolization), By Therapeutic Condition (Liver Cancer, Kidney Cancer, Neuroendocrine Tumours, Cardiovascular Diseases, Uterine Fibroids, Aneurysms, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), and Geography

Embolization Products Market size was valued at USD 1,764.9 Million in 2022 and is anticipated to grow at a CAGR of 8.7% over 2023-2029. Embolization products are medical devices used in a minimally invasive procedure called embolization, which is primarily employed to block or reduce blood flow in blood vessels. The purpose of embolization is to treat a variety of medical conditions, including bleeding, vascular malformations, and tumors. Embolization involves the insertion of embolic agents or materials into the blood vessels to occlude or block them. The increasing incidence of vascular diseases is a significant driver for the growth in revenues of the embolization products market. Vascular conditions, such as aneurysms, arteriovenous malformations, and peripheral artery disease, can be life-threatening if left untreated. As per the Society for Vascular Surgery (SVS) it is stated that every year in the US 2 million people are diagnosed with an abdominal aortic aneurysm. As the occurrence of vascular diseases is on the rise, the need for effective treatment options fuels the demand for embolization products, driving revenue growth for manufacturers and suppliers in the market.

Moreover, the growing awareness of minimally invasive therapies is a significant driver behind the increased sales of embolization products. Patients and healthcare providers alike are increasingly recognizing the advantages of minimally invasive procedures, such as reduced recovery time, shorter hospital stays, and diminished post-operative pain and scarring. Embolization procedures align with this trend as they are minimally invasive by nature, involving small incisions or catheter-based approaches. However, However, regulatory hurdles for the approval of new embolization products can slow down product innovation and growth of the market. Meanwhile, collaborations between medical device manufacturers and healthcare institutions or research organizations are creating several growth opportunities for the market. The global embolization products market is surging owing to the launch of innovative products in different markets to expand the portfolio and strengthen its position in the market. For instance, in June 2023, Boston Scientific Corporation announced the FDA 510(k) clearance for the Embold Soft and Packing coils, designed for use in a variety of embolization procedures.

Embolization Products Market Key Developments:        

• In May 2023, Boston Scientific launched the Obsidio Conformable Embolic, a new substance that combines the benefits of solid and liquid embolic, while overcoming challenges.
• In July 2021, Terumo Medical Corporation (TMC) introduced its AZUR Vascular Plug and PG Pro Peripheral Microcatheter which can be used to decrease or obstruct the flow of blood in the arteries of the peripheral vasculature, as well as to introduce diagnostic and therapeutic agents into the peripheral vasculature.